GSK690693 - ≥98%, high purity , Protein kinase C (PKC) inhibitor, CAS No.937174-76-0, Protein kinase C (PKC) inhibitor

Item Number
G127527
Grouped product items
SKUSizeAvailabilityPrice Qty
G127527-5mg
5mg
2
$117.90
G127527-10mg
10mg
2
$166.90
G127527-50mg
50mg
2
$533.90
G127527-100mg
100mg
2
$855.90

Novel ATP-competitive pan-Akt kinase inhibitor

Basic Description

Synonyms(R)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-yl-MeO)-1H-imidazo[4,5-c]pyridin-4-yl)-2-Me-but-3-yn-2-ol | UNII-GWH480321B | AKOS015904356 | NCGC00263181-01 | (-)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-((3S)-3-PIPERIDINYLMETHOXY)-1H
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsGSK-690693 is an ATP-competitive pan-Akt kinase inhibitor (IC50 values are 2, 13 and 9 nM for Akt1, 2 and 3 respectively). GSK-690693 also exhibits some inhibition for AMPK, PKA and PAK and PKC isoforms (IC50 < 100 nM). GSK-690693 displays antiprolifer
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionProtein kinase C (PKC) inhibitor
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Toxic, refer to SDS for further information. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Novel ATP-competitive pan-Akt kinase inhibitor.
GSK690693 has been used in western blotting and immunoprecipitations.

AI Insight

Product Properties

ALogP0.3

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid504768503
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504768503
IUPAC Name 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol
INCHI InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1
InChi Key KGPGFQWBCSZGEL-ZDUSSCGKSA-N
Canonical SMILES CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N
Isomeric SMILES CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N
WGK Germany 3
PubChem CID 16725726
Molecular Weight 425.48

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDateItem
K2228299Certificate of AnalysisSep 12, 2024 G127527
K2228301Certificate of AnalysisSep 12, 2024 G127527
K2228345Certificate of AnalysisSep 12, 2024 G127527
K2228346Certificate of AnalysisSep 12, 2024 G127527

Safety and Hazards(GHS)

Pictogram(s) GHS06
Signal Danger
Hazard Statements

H301:Toxic if swallowed

Precautionary Statements

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P301+P316:IF SWALLOWED: Get emergency medical help immediately.

WGK Germany 3

Related Documents

Reviews

Customer Reviews

References

1. Rhodes N, Heerding DA, Duckett DR, Eberwein DJ, Knick VB, Lansing TJ, McConnell RT, Gilmer TM, Zhang SY, Robell K et al..  (2008)  Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity..  Cancer Res,  68  (7): (2366-74).  [PMID:18381444] [10.1021/op500134e]
2. Heerding DA, Rhodes N, Leber JD, Clark TJ, Keenan RM, Lafrance LV, Li M, Safonov IG, Takata DT, Venslavsky JW et al..  (2008)  Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase..  J Med Chem,  51  (18): (5663-79).  [PMID:18800763] [10.1021/op500134e]

Solution Calculators